Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Intellipharmaceutics Intl Inc > Profile

Intellipharmaceutics Intl Inc (IPCI)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Sabby Capital

Hal Mintz

 0 $0 0%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1.
Captrust Financial Advisors
 0 $0 0%
News See All
13G Filing: Armistice Capital and Intellipharmaceutics Intl Inc (IPCI)

13G Filing: Armistice Capital and Intellipharmaceutics Intl Inc (IPCI)

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the...

Keep Reading →

December 5th, 2017 - Hedge Funds

13G Filing: Armistice Capital and IntelliPharmaCeutics Intl Inc (USA) (IPCI)

13G Filing: Armistice Capital and IntelliPharmaCeutics Intl Inc (USA) (IPCI)

                                                                                                                       [...

Keep Reading →

October 23rd, 2017 - Hedge Funds

Monday Movers In Biotech: Cempra Inc (CEMP) And IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Monday Movers In Biotech: Cempra Inc (CEMP) And IntelliPharmaCeutics Intl Inc (USA) (IPCI)

It’s going to be a good start to the week for a few companies in the biotech space, after a raft of positive news hit the wires on Friday.

Keep Reading →

February 27th, 2017 - Market Movers News Stock Analysis

IntelliPharmaCeutics Intl Inc (USA) (IPCI) Needs A Partner

IntelliPharmaCeutics Intl Inc (USA) (IPCI) Needs A Partner

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) just announced the submission of its New Drug Application (NDA) for Rexista, it’s bioequivalent OxyContin product.

Keep Reading →

November 28th, 2016 - News Stock Analysis

Raging Bull Portfolio: Abeona Therapeutics Inc (ABEO) And IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Raging Bull Portfolio: Abeona Therapeutics Inc (ABEO) And IntelliPharmaCeutics Intl Inc (USA) (IPCI)

This article has been removed due to violation of our Terms of Service.

Keep Reading →

November 7th, 2016 - News Stock Analysis

Here's Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today

Here's Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today

Stocks are extending losses on Tuesday, mainly due to healthcare sector, which is down over 2%, and slipping crude prices.

Keep Reading →

October 11th, 2016 - Market Movers News

Here's Why Mylan, Diamondback Energy, TESARO and Two Other Stocks Are Surging Today

Here's Why Mylan, Diamondback Energy, TESARO and Two Other Stocks Are Surging Today

Among the most notable gainers today are IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), Mylan NV (NASDAQ:MYL), Mobileiron Inc (NASDAQ:MOBL), TESARO Inc (NASDAQ:TSRO), and Diamondback Energy Inc...

Keep Reading →

October 10th, 2016 - Market Movers News

Here’s What You Need to Know About IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Here’s What You Need to Know About IntelliPharmaCeutics Intl Inc (USA) (IPCI)

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) is a tiny Canadian biotech with no approved products and a market capitalization of a little over $40 million at last count.

Keep Reading →

July 7th, 2016 - News Stock Analysis

These 4 Stocks are Enjoying a Green Day

These 4 Stocks are Enjoying a Green Day

At a time when the major indexes are in bull market territory, shares of Freeport-McMoRan Inc (NYSE:FCX), Big 5 Sporting Goods Corporation (NASDAQ:BGFV), IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI...

Keep Reading →

January 14th, 2016 - Hedge Funds Market Movers News

Click here to See All News
Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)